524506 — Coral Laboratories Share Price
0.000.00%
Last trade - 00:00- IN₹2.47bn
- IN₹1.60bn
- IN₹836.60m
- 47
- 40
- 96
- 69
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.33 | ||
| Price to Tang. Book | 1.33 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.82 | ||
| EV to EBITDA | 9.25 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.8% | ||
| Return on Equity | 9.5% | ||
| Operating Margin | 16.85% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 705.79 | 965.67 | 756.11 | 781.18 | 836.6 | n/a | n/a | -1.69% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -35.77 | +89.9 | -38.6 | -22.83 | +148.02 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC) and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops and ear drops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics and muscle relaxants. The Company also exports its products to various countries.
Directors
- Sushma Chinchane CFO (41)
- Ruchi Anjaria CCO
- Girish Dhameja EDR (36)
- Sheela Kamdar DRC
- Samir Sheth DRC (46)
- Sanket Mehta IND (36)
- Saurabh Shah IND
- Priyush Dhedhi NID (75)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- February 6th, 1997
- Public Since
- March 17th, 1994
- No. of Employees
- 109
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 3,572,600
- Address
- 503, 5th Floor, Dalamal House, MUMBAI, 400086
- Web
- https://corallab.com/
- Phone
- +91 2225008208
- Auditors
- M.A. Parekh & Associates
Upcoming Events for 524506
Q1 2025 Coral Laboratories Ltd Earnings Release
Q2 2025 Coral Laboratories Ltd Earnings Release
Similar to 524506
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
What is the Coral Laboratories share price?
As of Today at 20:05 UTC, shares in Coral Laboratories are trading at IN₹659.85. This share price information is delayed by 15 minutes.
How has the Coral Laboratories share price performed this year?
Shares in Coral Laboratories last closed at IN₹659.85 and the price had moved by +166.01% over the past 365 days. In terms of relative price strength the Coral Laboratories share price has outperformed the S&P BSE 100 Index by +103.26% over the past year.
What are the analyst and broker recommendations for Coral Laboratories?
The overall consensus recommendation for Coral Laboratories is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Coral Laboratories dividend yield?
Coral Laboratories does not currently pay a dividend.
Does Coral Laboratories pay a dividend?
Coral Laboratories does not currently pay a dividend.
When does Coral Laboratories next pay dividends?
Coral Laboratories does not currently pay a dividend.
How do I buy Coral Laboratories shares?
To buy shares in Coral Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Coral Laboratories?
As of the previous close price of IN₹659.85, shares in Coral Laboratories had a market capitalisation of IN₹2.36bn.
Where are Coral Laboratories shares listed?
Here are the trading details for Coral Laboratories:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524506
What kind of share is Coral Laboratories?
Based on an overall assessment of its quality, value and momentum Coral Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Coral Laboratories share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Coral Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Coral Laboratories. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +32.46%.
As of the last closing price of IN₹659.85, shares in Coral Laboratories were trading +67.58% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Coral Laboratories PE Ratio?
The Coral Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹659.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Coral Laboratories?
Coral Laboratories' management team is headed by:
- Sushma Chinchane - CFO
- Ruchi Anjaria - CCO
- Girish Dhameja - EDR
- Sheela Kamdar - DRC
- Samir Sheth - DRC
- Sanket Mehta - IND
- Saurabh Shah - IND
- Priyush Dhedhi - NID